Noah Labs

What Noah Labs does

Noah Labs is a Berlin-based MedTech company founded in 2021 that develops AI-powered cardiovascular telemonitoring solutions for cardiologists, hospitals, GP practices, and heart failure patients across Europe and the United States. The company's product portfolio consists of two integrated offerings: Noah Labs Ark, a CE-marked Class IIa medical device software platform that aggregates data from external devices (smartwatches, blood pressure monitors, scales, ECGs) and cardiac implants (via integrations with Medtronic, Biotronik, Boston Scientific, Abbott, and Withings) into a unified dashboard with intelligent alerts; and Noah Labs Vox, a proprietary AI voice analysis algorithm trained on deep-learning models that detects vocal biomarkers of cardiac decompensation up to 21-29 days before hospitalization, with clinical trials demonstrating 84% sensitivity versus 36% for weight-based monitoring.

Noah Labs generates revenue primarily through a per-patient SaaS subscription model for Ark telemonitoring, with healthcare providers able to bill statutory and private health insurers in Germany via the EBM standardized assessment scale. Service packages include device provisioning (shipped within 48 hours of enrollment), setup, and training. The go-to-market motion is enterprise sales-led, targeting cardiology practices, hospitals, and clinics through direct engagement, clinical trial partnerships, and conference presence at events such as Heart Failure 2026 and ESC Digital & AI Summit. The company reports deployment across 75+ European practices and clinics with 40,000+ patient days of monitoring.

The company maintains a dual entity structure (Noah Labs GmbH in Berlin and Noah Labs Inc. in Boston) and has secured approximately €6.4 million in total funding across seed, grant, and EIC Accelerator rounds, with a clinical evidence base spanning five multicentre trials at leading institutions including Mayo Clinic, UCSF, Charité Berlin, UMC Maastricht, and Clinic Barcelona. Regulatory milestones include ISO 13485 certification (2023), EU MDR Class IIa approval for Ark (April 2024), and FDA Breakthrough Device Designation for Vox (March 2026).

Name

Noah Labs

Legal name

Noah Labs GmbH

Website

https://noah-labs.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Noah Labs is a Berlin-based MedTech company that develops AI-powered cardiovascular telemonitoring platforms (Ark) and voice-based heart failure detection algorithms (Vox), serving cardiologists, hospitals, and clinics across Europe and the US.

Ownership category

akta.pro rank

Product category

Cardiovascular Telemonitoring Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Cardiology Telemedicine Platforms (HLALAGAB)

akta.pro secondary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

Keywords

• Cardiac telemonitoring software
• Heart failure monitoring
• AI voice biomarkers
• Remote patient monitoring
• Medical device software

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Noah Labs Ark SaaS Subscription: Software-as-a-service subscription model for remote patient monitoring. Healthcare providers pay per patient enrolled in telemonitoring program. In Germany, telemonitoring can be billed per patient to statutory and private health insurers per EBM standardized assessment scale.
2. Device and Onboarding Services: Professional services including device provisioning, setup, and training included in service package. Company ships medical devices within 48 hours of patient enrollment.
3. Noah Labs Vox (Future): Voice-based AI diagnostic software pending FDA and CE regulatory clearance. Expected to generate additional subscription revenue upon commercial launch.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Noah Labs develops and sells Noah Labs Ark, a CE-marked Class IIa medical device software platform for cardiovascular telemonitoring that integrates external devices (smartwatches, blood pressure monitors, scales, ECGs), cardiac implants, and the company's AI-powered Noah Labs Vox voice analysis algorithm. The platform enables healthcare providers to remotely monitor chronic heart failure patients, detect cardiac decompensation weeks before hospitalization, and deliver structured telemonitoring programs with intelligent dashboards and automatic notifications.

Product overview

Noah Labs offers a platform-plus-AI-module architecture consisting of two products: Noah Labs Ark (the core telemonitoring platform) and Noah Labs Vox (an add-on AI voice analysis module). Noah Labs Ark is a CE-marked Class IIa medical device that enables remote monitoring of chronic cardiovascular diseases through integration with external medical devices (smartwatches, ECGs, blood pressure monitors, scales) and cardiac implants from major manufacturers (Medtronic, Biotronik, Boston Scientific, Abbott, Withings). The platform includes the Noah Labs Vox AI algorithm, which analyzes weekly voice recordings to detect early signs of cardiac decompensation weeks before hospitalization would occur. Together, these products provide comprehensive, AI-powered cardiovascular telemonitoring that combines structured vital signs data with voice-based biomarkers.

Differentiator

Problem solved

Functional benefit

Brands

• Noah Labs Ark: CE-marked Class IIa medical device software for telemonitoring of chronic diseases, integrating external devices, implants, and AI-powered heart failure detection algorithm.
• Noah Labs Vox

Products and services

• Noah Labs Ark Class IIa CE-marked medical device software platform for telemonitoring of chronic cardiovascular diseases. Integrates external devices (smartwatches, blood pressure monitors, scales, ECGs), cardiac implants from Medtronic, Biotronik, Boston Scientific, and Abbott, plus Withings consumer devices, and the Noah Labs Vox AI algorithm. Provides an intelligent dashboard with automatic notifications to healthcare providers. Designed for cardiologists, hospitals, GP practices, and healthcare systems running remote patient monitoring programs.
• Noah Labs Vox AI-powered voice analysis algorithm that detects cardiac decompensation by analyzing weekly voice recordings (sustained vowel /i/ samples) via deep-learning models trained on proprietary audio datasets. Detects vocal biomarkers of heart failure deterioration up to 21-29 days before hospitalization at 84% sensitivity. Integrated into the Noah Labs Ark platform and targeted at healthcare providers managing chronic heart failure patients.

Quantifiable outcome

• 84% sensitivity for heart failure hospitalization detection (vs 36% for weight monitoring)
• +8 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature3 records

Partnerships

20 partnerships are on record, tiered flagship, core and minor.

• Mayo ClinicflagshipStrategic or Co-development Partner · 26 March 2026Clinical validation partner for voice biomarker technology. Conducting VAMP-HF study investigating voice analysis as biomarker for heart failure. One of leading US medical institutions.
• UCSF (University of California, San Francisco)coreStrategic or Co-development Partner · 26 March 2026Clinical validation partner for Vox AI voice-based heart failure monitor. Partnership in five multicentre clinical trials.
• DHZB Foundation (German Heart Center Berlin Foundation)flagshipStrategic or Co-development Partner · 8 April 2024Strategic collaboration and investment agreement for developing voice-based biomarkers for heart failure. Includes joint clinical research and development, as well as investment in company. First external investment of DHZB Foundation. Combined with Charité Universitätsmedizin Berlin to oversee German Heart Centre at Charité (DHZC).
• Maastricht University Medical Center+ (UMC Maastricht)coreStrategic or Co-development Partner · 1 January 2024Clinical trial partner for PRE-DETECT-HF study. Provides clinical expertise and research infrastructure. Leading academic medical center in cardiology.
• Clinic BarcelonacoreStrategic or Co-development Partner · 1 January 2024Clinical trial partner for PRE-DETECT-HF study. Renowned cardiology center contributing clinical experience and patient access.
• DKV SaludminorOthers · 1 January 2024Part of PRE-DETECT-HF consortium. Spanish health insurance provider contributing insurance and regulatory perspective.
• ProductLife GroupminorOthers · 1 January 2024Part of PRE-DETECT-HF consortium. Provides regulatory and compliance expertise.
• Institute for Policy Evaluation (IPE)minorOthers · 1 January 2024Part of PRE-DETECT-HF consortium. Contributes economic and policy evaluation perspective.
• IDIBAPS (Fundació de Recerca Clínic Barcelona)minorOthers · 1 January 2024Part of PRE-DETECT-HF consortium. Barcelona-based research institute contributing clinical research expertise.
• German Foundation for the Chronically Ill (DSCC)minorOthers · 1 January 2024Part of PRE-DETECT-HF consortium. Patient advocacy organization contributing patient perspective.
• Charité Berlin (German Heart Centre at Charité)flagshipStrategic or Co-development PartnerConducts multiple trials together with German Heart Centre at Charité (DHZC). DHZB Stiftung has invested in Noah Labs. Clinical trial site for VAMP-HF and TIM-HF3 Voice studies.
• American Heart AssociationcoreStrategic or Co-development PartnerNoah Labs is a member of AHA's Center for Health Technology and Innovation. Provides credibility and access to cardiovascular health technology ecosystem.
• Entrepreneur FirstminorGTM or Marketing PartnerIncubator program where founders met. Entrepreneur First is leading technology incubator based in London. Instrumental in company's formation journey.
• Creative Destruction LabminorGTM or Marketing PartnerGraduated from prestigious CDL program in 2024 and presented at CDL Super Session in Toronto, Canada. Provides mentorship and access to scaling expertise.
• Google for StartupsminorGTM or Marketing PartnerCompleted 'Google for Startups Growth Academy: AI for Health' in 2025. Provides access to Google's startup resources and credibility.
• WithingscoreTechnology or IntegrationDevice integration partner. Connected health devices (scales, blood pressure monitors, watches) integrated with Noah Labs Ark platform.
• MedtroniccoreTechnology or IntegrationDevice integration partner. Cardiac devices and implants integrated with Noah Labs Ark platform via API.
• BiotronikcoreTechnology or IntegrationDevice integration partner. Cardiac implants integrated with Noah Labs Ark platform for seamless data display.
• Boston ScientificcoreTechnology or IntegrationDevice integration partner. Cardiac devices integrated with Noah Labs Ark platform.
• AbbottcoreTechnology or IntegrationDevice integration partner. Cardiac implants and devices integrated with Noah Labs Ark platform.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Biofourmis: AI-driven remote patient monitoring and predictive analytics platform for chronic disease management including heart failure. Direct peer in AI-augmented continuous monitoring for cardiology.
• Eko Health: AI-powered cardiac monitoring company combining digital stethoscopes with machine learning algorithms to detect heart disease. Direct competitor in applying AI to cardiac diagnostics for clinicians and a comparable AI-first cardiology platform.
• iRhythm Technologies: Provider of Zio cardiac monitoring patches and AI-based ECG analysis for arrhythmia detection. Direct competitor in ambulatory cardiac monitoring with FDA-cleared AI algorithms serving cardiologists.
• AliveCor: KardiaMobile ECG device maker with FDA-cleared AI algorithms for atrial fibrillation detection. Direct peer in consumer- and clinician-facing AI cardiac diagnostics.
• Huma: Digital health platform providing remote patient monitoring with AI-driven predictive analytics across multiple conditions including cardiovascular. Comparable RPM platform with hospital partnerships and FDA-listed software.
• Vivify Health: Remote patient monitoring platform with chronic disease management including cardiac care pathways. Comparable RPM platform targeting payers and providers in cardiovascular and other chronic conditions.

Broad incumbents

• Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, provides BodyGuardian remote cardiac monitoring systems. Direct overlap in cardiac RPM with established presence and now backed by a major implant manufacturer.
• Philips Remote Cardiac Monitoring: Philips offers broad cardiology portfolio including remote cardiac monitoring and ECG management as part of its connected care segment. Comparable cardiac telemetry offerings from a major medtech incumbent.

Emerging players

• Cordio Medical: Israeli startup developing AI-based voice analysis for heart failure detection (HearO). Closest direct competitor to Noah Labs Vox, using voice biomarkers for cardiac decompensation prediction.
• Cardiologs: AI-based ECG analysis platform (acquired by Philips) for cardiac arrhythmia detection. Comparable AI-first cardiac diagnostics approach targeting cardiologists and electrophysiologists.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/noah-labs
• Instagraminstagram.com/noahlabsgmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds9 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noah Labs